The European infusion therapy devices market is anticipated to grow at a CAGR of 5.8% during the forecast period. Major European economies contributing to the market are the UK, Germany and France. Various biotech companies are working in the field of infusion therapy devices in these economies. The market is being significantly driven by the increasing number of surgeries performed coupled with the significant prevalence of chronic diseases in the region. As per the Eurostat, considerable growth in appendectomies performed with the use of keyhole surgery was reported in the EU hospitals in 2017. Laparoscopic appendectomy was the most common procedure in 2017. Among the 23 EU Member States, four Member States, including Finland, Poland, Lithuania and Estonia (2013-2017) were reported the frequency of this procedure more than doubled, while there were even faster expansions in Slovenia (3.5 times as high in 2017 as in 2012), Cyprus (5.2 times; 2013-2017) and Malta (6.3 times).

Visit for Global Infusion Therapy Devices Market Report at: https://www.omrglobal.com/industry-reports/infusion-therapy-devices-market-size

The European infusion therapy devices market is segmented on the basis of product type, application, and end-user. Based on the product type, the market is classified into infusion pumps and consumables & accessories. Based on the application, the market is segregated into oncology, diabetes, gastroenterology, analgesia, hematology, and others. The end-user segment is classified into hospitals, home care, and ambulatory surgery centers.

The major players contributing to the growth of the European infusion therapy devices market include B. Braun Melsungen AG, Medtronic PLC, Novartis AG, and Terumo Corp. The players operating in the market adopt various strategies such as technology development, product launch, merger and acquisitions for gaining a sustainable position in the market that further propels the growth of the market. For instance, in July 2019, B. Braun Melsungen AG announced the integration of Space infusion pump systems with TeleTracking Technologies, Inc.’s RTLS Asset Tracking solution. This integration demonstrates the company’s ongoing focus on solving operational challenges and improving patient safety, and in turn, accelerating its revenue in the infusion pump segment.

Research Methodology

The market study of the European infusion therapy device market is incorporated by extensive primary and secondary research conducted by a research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The OMR team collects facts and data related to the market from different geographies to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. The numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analysts to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts to get first-hand information. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market
• Authentic public databases such as the World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), American Cancer Society (ACS), National Institutes of Health (NIH), American Heart Association (AHA), and International Diabetes Federation (IDF).
• Whitepapers, research-papers and news blogs
• Company websites and their product catalog

The report is intended for infusion therapy device market players, potential entrants, medical device companies, healthcare providers, investment companies, research institutes, universities, government organizations for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation

1. European Infusion Therapy Devices Market Research and Analysis by Product Type.

2. European Infusion Therapy Devices Market Research and Analysis by End-User. 

3. European Infusion Therapy Devices Market Research and Analysis by Application.

The Report Covers

• Comprehensive research methodology of the European infusion therapy devices market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the European infusion therapy devices market.
• Insights about market determinants which are stimulating the European infusion therapy devices market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.